The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MET as a prognostic biomarker of survival in a large cohort of patients with gastroesophageal cancer (GEC).
 
Daniel Virgil Thomas Catenacci
Honoraria - Amgen; Foundation Medicine; Genentech/Roche; Genmab; Lilly; OncoPlex Diagnostics; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Genentech/Roche; OncoPlex Diagnostics
Speakers' Bureau - Foundation Medicine; Lilly; OncoPlex Diagnostics
Research Funding - Amgen; Genentech; OncoPlex Diagnostics
 
Rui Tang
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Kelly Smith Oliner
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Agnes Ang
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Robert D. Loberg
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Emily O'Day
No Relationships to Disclose
 
Peng Xu
No Relationships to Disclose
 
Les Henderson
No Relationships to Disclose
 
Annamaria Ruzzo
No Relationships to Disclose
 
Francesco Graziano
No Relationships to Disclose